http://www.medcitynews.com/2009/08/new-leader-of-bioinnovation-institute-in-akron-climbing-mount-everest-of-social-and-medical-transformation/?utm_source=rss&utm_medium=rss&utm_campaign=new-leader-of-bioinnovation-institute-in-akron-climbing-mount-everest-of-social-and-medical-transformation MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2009/08/new-leader-of-bioinnovation-institute-in-akron-climbing-mount-everest-of-social-and-medical-transformation/comment-page-1/#comment-17667 Procter & Gamble announces sale of prescription drug unit … and cornhole — MedCity Weekend Rounds, Aug. 29, 2009 : MedCity News Sun, 30 Aug 2009 13:56:34 +0000 http://www.medcitynews.com/?p=10684#comment-17667 [...] In other news, EyeScience Labs in Columbus, which makes supplements for certain eye problems, raised just over $400,000 of a half-million dollar equity round, Diagnostic Hybrids Inc. in Athens, Ohio, won Food and Drug Administration marketing clearance for a thyroid test, and PercuVision in Columbus won FDA marketing clearance for its device that guides medical staff through a urethral catheterizations. Meanwhile, the emerging BioInnovation Institute in Akron hired its first president and chief executive: Dr. Frank L. Douglas, founder and former executive director of the Massachusetts Institute of Technology’s Center of Biomedical Innovation. Douglas, who starts Sept. 1, sees the Akron institute as “the Mount Everest of social and medical transformation.” [...] [...] In other news, EyeScience Labs in Columbus, which makes supplements for certain eye problems, raised just over $400,000 of a half-million dollar equity round, Diagnostic Hybrids Inc. in Athens, Ohio, won Food and Drug Administration marketing clearance for a thyroid test, and PercuVision in Columbus won FDA marketing clearance for its device that guides medical staff through a urethral catheterizations. Meanwhile, the emerging BioInnovation Institute in Akron hired its first president and chief executive: Dr. Frank L. Douglas, founder and former executive director of the Massachusetts Institute of Technology’s Center of Biomedical Innovation. Douglas, who starts Sept. 1, sees the Akron institute as “the Mount Everest of social and medical transformation.” [...]

]]>